Inventage Lab Inc. Logo

Inventage Lab Inc.

Develops drug delivery systems using microfluidics for chronic diseases and gene therapies.

389470 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 성남시 중원구 둔촌대로388번길 24, 101호, 601호, 612호, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Inventage Lab Inc. is a clinical-stage biopharmaceutical company that develops advanced drug delivery systems (DDS) for chronic and intractable diseases. The company's core innovation is its proprietary Laminar-FLUIDigm™ platform, which utilizes microfluidics for the research and development of novel pharmaceuticals. Inventage Lab operates two primary technology platforms: IVL-DrugFluidic® for developing and manufacturing microsphere-based long-acting injectables, and IVL-GeneFluidic® for the formulation of Lipid Nanoparticles (LNPs) used in gene therapies. Its therapeutic pipeline focuses on unique-in-class treatments for conditions like Alzheimer's disease and androgenic alopecia, drug re-discovery for autoimmune disorders, and joint development of treatments for HIV and mRNA-based therapies.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Inventage Lab Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-10 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험결과) (알코올 의존성 및 opioid 의존성 치료제(IVL3004) 및 다발성 경화증 …
Korean 15.3 KB
2025-08-27 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-08-08 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB
2025-08-08 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.2 KB
2025-07-31 00:00
M&A Activity
투자판단관련주요경영사항 (FGF-21기반 mRNA-LNP 대사성 질환치료제 독점적 권리 도입 계약 체결)
Korean 10.9 KB

Automate Your Workflow. Get a real-time feed of all Inventage Lab Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Inventage Lab Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
TOWA PHARMACEUTICAL CO.,LTD. Logo
Manufactures and markets high-quality, accessible generic drugs for various therapeutic areas.
Japan 4553
TSUMURA & CO. Logo
A leader in Japanese Kampo herbal medicine, producing prescription and OTC formulations.
Japan 4540
TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo
Turkish producer of pharmaceuticals, specializing in IV solutions and vaccines for hospitals.
Türkiye TRILC
UCB Logo
UCB
Biopharma firm developing treatments for severe neurological and immunological diseases.
Belgium UCB
Develops biopharma therapies for endocrinology, ophthalmology, and dermatology needs.
Hong Kong N/A
UNION KOREA PHARM CO.,Ltd Logo
Develops and manufactures prescription drugs like antibiotics and analgesics for global markets.
South Korea 080720
Univo Pharmaceuticals Ltd. Logo
Vertically integrated biopharma firm developing medical cannabis treatments with a focus on CNS.
Israel UNVO-M
Valbiotis Logo
Develops clinically tested, plant-based supplements for metabolic & cardiovascular health.
France ALVAL
Valneva SE Logo
Develops and commercializes vaccines for infectious diseases like chikungunya, Lyme, and Zika.
France VLA
Vaxcell-Bio Therapeutics Logo
Develops CAR-T and CAR-NK immunotherapies for solid tumors and canine lymphoma.
South Korea 323990

Talk to a Data Expert

Have a question? We'll get back to you promptly.